UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Emerging pharmacotherapy for inflammatory bowel diseases Review article
2022
Authors:  Hua Luo;  Guiqing Cao;  Chun Luo;  Dechao Tan;  Chi Teng Vong ; et al.
Favorite | TC[WOS]:47 TC[Scopus]:51  IF:9.1/9.0 | Submit date:2022/05/04
Emerging Pharmacotherapy  Ibd  Molecular Pathogenesis  Therapeutic Targets  
Panax notoginseng Saponins Modulate the Inflammatory Response and Improve IBD-Like Symptoms via TLR/NF-κB and MAPK Signaling Pathways Journal article
Hua Luo, Chi Teng Vong, Dechao Tan, Jinming Zhang, Hua Yu, Lin Yang, Chen Zhang, Chun Luo, Zhangfeng Zhong, Yitao Wang. Panax notoginseng Saponins Modulate the Inflammatory Response and Improve IBD-Like Symptoms via TLR/NF-κB and MAPK Signaling Pathways[J]. The American Journal of Chinese Medicine|, 2021, 49(04), 925-939.
Authors:  Hua Luo;  Chi Teng Vong;  Dechao Tan;  Jinming Zhang;  Hua Yu; et al.
Favorite | TC[WOS]:16 TC[Scopus]:16  IF:4.8/5.0 | Submit date:2022/08/30
Dextran Sulfate Sodium  Inflammatory Bowel Disease  Mapk  Nf-κb Signaling Pathways  Panax Notoginseng Saponins.